Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.


Journal

Cold Spring Harbor perspectives in medicine
ISSN: 2157-1422
Titre abrégé: Cold Spring Harb Perspect Med
Pays: United States
ID NLM: 101571139

Informations de publication

Date de publication:
03 09 2019
Historique:
pubmed: 31 5 2018
medline: 25 9 2020
entrez: 31 5 2018
Statut: epublish

Résumé

Both hepatitis A virus (HAV) and hepatitis E virus (HEV) cause self-limited infections in humans that are preventable by vaccination. Progress in characterizing adaptive immune responses against these enteric hepatitis viruses, and how they contribute to resolution of infection or liver injury, has therefore remained largely frozen for the past two decades. How HAV and HEV infections are so effectively controlled by B- and T-cell immunity, and why they do not have the same propensity to persist as HBV and HCV infections, cannot yet be adequately explained. The objective of this review is to summarize our understanding of the relationship between patterns of virus replication, adaptive immune responses, and acute liver injury in HAV and HEV infections. Gaps in knowledge, and recent studies that challenge long-held concepts of how antibodies and T cells contribute to control and pathogenesis of HAV and HEV infections, are highlighted.

Identifiants

pubmed: 29844218
pii: cshperspect.a033472
doi: 10.1101/cshperspect.a033472
pmc: PMC6531370
mid: NIHMS1024454
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI126890
Pays : United States

Informations de copyright

Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Références

J Virol. 2000 Dec;74(23):10950-7
pubmed: 11069989
J Med Virol. 2002 Jan;66(1):40-8
pubmed: 11748657
Clin Diagn Lab Immunol. 2002 Sep;9(5):1072-8
pubmed: 12204962
Vaccine. 2003 Jun 2;21(19-20):2607-15
pubmed: 12744897
Clin Diagn Lab Immunol. 2003 Jul;10(4):579-86
pubmed: 12853389
Immunity. 2003 Aug;19(2):225-34
pubmed: 12932356
J Infect Dis. 1992 Feb;165(2):273-80
pubmed: 1309847
J Virol. 1992 Apr;66(4):2208-16
pubmed: 1312628
Medicine (Baltimore). 1992 Jan;71(1):14-23
pubmed: 1312659
Vaccine. 1992;10 Suppl 1:S148-51
pubmed: 1335648
Arch Virol Suppl. 1992;4:3-4
pubmed: 1450708
Vaccine. 1992;10 Suppl 1:S18-20
pubmed: 1475999
J Am Med Assoc. 1951 Oct 20;147(8):714-9
pubmed: 14873541
J Exp Med. 1952 Mar;95(3):231-9
pubmed: 14927787
Indian J Gastroenterol. 1992 Jul;11(3):113-6
pubmed: 1506045
Am J Public Health. 2004 Sep;94(9):1620-6
pubmed: 15333325
Proc Soc Exp Biol Med. 1950 Apr;73(4):603-5
pubmed: 15417611
J Exp Med. 1950 Sep;92(3):271-81
pubmed: 15436936
J Gen Virol. 2005 Oct;86(Pt 10):2747-51
pubmed: 16186228
J Gen Virol. 2006 Mar;87(Pt 3):697-704
pubmed: 16476993
J Infect Dis. 1990 Jan;161(1):7-13
pubmed: 1688601
J Gen Virol. 2007 Mar;88(Pt 3):903-11
pubmed: 17325363
Viral Immunol. 2007 Spring;20(1):56-65
pubmed: 17425421
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e105-10
pubmed: 17645467
J Immunol Methods. 2007 Dec 1;328(1-2):152-61
pubmed: 17905301
N Engl J Med. 2007 Oct 25;357(17):1685-94
pubmed: 17947390
J Med Virol. 2008 Jan;80(1):95-101
pubmed: 18041018
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
J Med Virol. 2008 May;80(5):824-32
pubmed: 18360896
J Infect Dis. 1991 Jan;163(1):7-11
pubmed: 1845810
Intervirology. 2008;51(5):322-7
pubmed: 19018147
Behring Inst Mitt. 1991 Jul;(89):226-30
pubmed: 1930098
J Clin Microbiol. 2009 Jun;47(6):1906-10
pubmed: 19369433
N Engl J Med. 2009 Sep 3;361(10):1025-7
pubmed: 19726781
J Clin Microbiol. 2010 Apr;48(4):1112-25
pubmed: 20107086
J Infect Dis. 2010 Sep 15;202(6):835-44
pubmed: 20695798
Virol J. 2010 Sep 06;7:213
pubmed: 20815928
Am J Med Sci. 1946 Aug;212(2):129-38
pubmed: 20996954
PLoS One. 2010 Oct 21;5(10):e13560
pubmed: 21042408
J Hepatol. 2011 Feb;54(2):201-8
pubmed: 21056495
Science. 1990 Mar 16;247(4948):1335-9
pubmed: 2107574
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2438-43
pubmed: 21262830
J Clin Invest. 2011 Mar;121(3):1111-8
pubmed: 21339644
Gastroenterology. 2011 May;140(5):1481-9
pubmed: 21354150
Emerg Infect Dis. 2011 Apr;17(4):734-7
pubmed: 21470474
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11223-8
pubmed: 21690403
J Viral Hepat. 2011 Oct;18(10):e603-8
pubmed: 21914082
Hepatology. 2012 Mar;55(3):695-708
pubmed: 22006345
J Gen Virol. 2012 Apr;93(Pt 4):754-60
pubmed: 22170633
PLoS One. 2012;7(2):e31822
pubmed: 22384080
Gastroenterology. 2012 Jun;142(7):1516-25.e3
pubmed: 22430395
Emerg Infect Dis. 2012 May;18(5):869-72
pubmed: 22516170
Rev Med Virol. 2012 Sep;22(5):339-49
pubmed: 22645002
J Exp Med. 2012 Jul 30;209(8):1481-92
pubmed: 22753925
J Gastroenterol. 2013 Feb;48(2):147-58
pubmed: 23104469
Immunology. 1990 Jan;69(1):14-9
pubmed: 2312151
Infection. 1979;7(6):303-5
pubmed: 232698
Nature. 2013 Apr 18;496(7445):367-71
pubmed: 23542590
Diagn Microbiol Infect Dis. 2013 May;76(1):116-8
pubmed: 23608351
J Immunol. 2013 Jul 1;191(1):127-34
pubmed: 23729443
PLoS One. 2013 Oct 17;8(10):e78914
pubmed: 24147144
J Virol. 1987 Feb;61(2):491-8
pubmed: 2433464
Clin Microbiol Rev. 2014 Jan;27(1):139-65
pubmed: 24396140
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8281-5
pubmed: 2460866
Gut. 2015 Aug;64(8):1303-13
pubmed: 25007815
J Infect Dis. 1989 Aug;160(2):209-17
pubmed: 2503564
Virology. 2014 Nov;468-470:565-580
pubmed: 25277499
Nature. 2015 Jan 1;517(7532):85-88
pubmed: 25327248
J Clin Invest. 2015 Jan;125(1):169-76
pubmed: 25415438
J Clin Exp Hepatol. 2013 Jun;3(2):134-40
pubmed: 25755487
N Engl J Med. 2015 Jun 4;372(23):2265-6
pubmed: 26039604
J Clin Microbiol. 2015 Nov;53(11):3547-52
pubmed: 26338861
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2132-9
pubmed: 26787701
J Viral Hepat. 2016 Apr;23(4):305-15
pubmed: 26852892
J Virol. 2016 Mar 28;90(8):4232-4242
pubmed: 26865708
Sci Rep. 2016 Feb 25;6:21855
pubmed: 26911447
J Infect. 2016 Jun;72(6):723-730
pubmed: 26947133
J Viral Hepat. 2016 Jul;23(7):569-75
pubmed: 26990022
Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):e23-e25
pubmed: 27055386
Sci Rep. 2016 Apr 28;6:25141
pubmed: 27122081
Sci Rep. 2016 May 06;6:25482
pubmed: 27150018
Euro Surveill. 2016 Sep 1;21(35):
pubmed: 27608433
Hepatology. 2016 Dec;64(6):1934-1950
pubmed: 27631819
Science. 2016 Sep 30;353(6307):1541-1545
pubmed: 27633528
Joint Bone Spine. 2017 Mar;84(2):217-219
pubmed: 27836355
MBio. 2016 Dec 6;7(6):
pubmed: 27923925
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):770-775
pubmed: 28074040
PLoS One. 2017 Mar 22;12(3):e0174070
pubmed: 28328941
J Virol. 1988 Oct;62(10):3756-63
pubmed: 2843673
Biochimie. 2017 Oct;141:70-79
pubmed: 28483690
J Infect. 1988 Nov;17(3):265-70
pubmed: 2851022
Liver Int. 2018 Feb;38(2):266-277
pubmed: 28718943
MBio. 2017 Sep 5;8(5):
pubmed: 28874468
J Virol. 2017 Oct 27;91(22):
pubmed: 28878075
J Hepatol. 2017 Sep 5;:null
pubmed: 28887164
Gastroenterology. 2018 Jan;154(1):211-223.e8
pubmed: 28958858
Gastroenterology. 2018 Mar;154(4):1047-1060
pubmed: 29229400
Immunity. 2018 Jan 16;48(1):161-173.e5
pubmed: 29305140
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29440324
Transplant Direct. 2018 Feb 02;4(2):e341
pubmed: 29464202
Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):
pubmed: 29500305
Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):null
pubmed: 29661811
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4773-4778
pubmed: 29669922
Cold Spring Harb Perspect Med. 2019 May 1;9(5):null
pubmed: 29712682
Cold Spring Harb Perspect Med. 2019 Jul 1;9(7):null
pubmed: 29735580
Hepatology. 1986 Nov-Dec;6(6):1308-14
pubmed: 3025069
Ann Intern Med. 1987 Feb;106(2):221-6
pubmed: 3026213
J Infect Dis. 1987 Jul;156(1):56-63
pubmed: 3110307
J Gen Virol. 1988 Mar;69 ( Pt 3):731-8
pubmed: 3127543
Indian J Med Res. 1985 Jan;81:18-9
pubmed: 3921458
J Immunol. 1985 Sep;135(3):2140-4
pubmed: 3926897
J Hepatol. 1986;2(1):19-23
pubmed: 3950361
J Med Virol. 1985 Jun;16(2):163-9
pubmed: 4009149
Science. 1973 Dec 7;182(4116):1026-8
pubmed: 4356028
Med Microbiol Immunol. 1984;173(1):9-17
pubmed: 6088963
J Infect Dis. 1984 Sep;150(3):461
pubmed: 6090544
J Virol. 1984 Nov;52(2):465-73
pubmed: 6208377
J Clin Microbiol. 1980 Jun;11(6):710-6
pubmed: 6253518
Infect Immun. 1981 Apr;32(1):388-93
pubmed: 6260685
J Med Virol. 1981;7(3):233-9
pubmed: 6270280
J Med Virol. 1981;7(4):273-86
pubmed: 6278066
J Med Virol. 1983;11(4):287-94
pubmed: 6308139
J Infect Dis. 1983 Dec;148(6):1033-9
pubmed: 6317766
Intervirology. 1983;20(1):23-31
pubmed: 6409836
J Infect Dis. 1995 Oct;172(4):927-33
pubmed: 7561211
J Infect Dis. 1995 Mar;171 Suppl 1:S40-3
pubmed: 7876647
J Infect Dis. 1995 Mar;171 Suppl 1:S9-14
pubmed: 7876654
J Med Virol. 1994 Jul;43(3):249-51
pubmed: 7931186
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10198-202
pubmed: 7937861
J Infect Dis. 1994 Sep;170(3):517-21
pubmed: 8077708
Lancet. 1993 Jan 16;341(8838):149-50
pubmed: 8093748
Lancet. 1993 May 22;341(8856):1355
pubmed: 8098491
J Med Virol. 1993 Aug;40(4):334-8
pubmed: 8228927
J Clin Microbiol. 1996 Mar;34(3):707-13
pubmed: 8904442
J Infect Dis. 1997 Jul;176(1):9-19
pubmed: 9207344
J Infect Dis. 1997 Sep;176(3):593-601
pubmed: 9291304
Vaccine. 1997 Dec;15(17-18):1834-8
pubmed: 9413090

Auteurs

Christopher M Walker (CM)

Center for Vaccines and Immunity, The Research Institute at Nationwide Children's, Columbus, Ohio 43004.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH